Skip to main content
. 2022 Mar 9;12:844390. doi: 10.3389/fonc.2022.844390

Table 1.

Characteristics of the studies included.

Author Region Gold standard PL* Study type Number Gender (F/M) Age, years TNM edition Histopathological composition UOCA volume, ml Equipment
Wang (22) China Pathology E R 206 95/111 59.7 ± 11.3 AJCC, 8th NS NS Acuson Sequoia-512
Shen (23) China Pathology C R 59 14/45 51.4 ± 10.7 NS NS 500–800 NS
Li (14) China Pathology E R 100 42/58 62.3 ± 2.6 AJCC, 8th Well, 10; moderately, 21; poorly, 66 500–800 NS
Wang (15) China Pathology E R 158 52/106 59.5 ± 10.6 NS Well, 22; moderately, 33; poorly, 65; signet ring, 16; mucinous, 8; squamous carcinoma, 1 500 Acuson Sequoia-512
He (13) China Pathology E R 54 18/36 61.0 ± 9.7 AJCC, 7th NS 500–800 Philips iU22
Li (24) China Pathology E P 350 105/245 63.6 ± 11.8 AJCC, 6th NS 500 Acuson Sequoia-512
Zheng (25) China Pathology E R 162 35/127 58.3 ± 11.3 NS Well, 34; moderately, 31; poorly, 68; signet ring, 29 500 Acuson Sequoia-512
Chen (26) China Pathology C R 143 54/89 56.0 ± 11.4 NS NS 600 Acuson Sequoia-512

*PL, publication language; C, Chinese; E, English; P, prospective; R, retrospective; UOCA, ultrasonic oral contrast agent; NS, not specified.